Check your eligibility now & get in touch with a study center
CHECK ELIGIBILITY

Test IRB API push 4

To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource
utilization.

Detailed Description

Simple Text Block

You can use content blocks to arrange your articles, large texts, instructions. Combine these blocks with media blocks to add illustrations and video tutorials. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links.

Call 1800-9860-568 now to find out if you are eligible.

Age icon
Age
0 - 99
Gender icon
Gender
All
NCT ID icon
NCT ID
NCT9255748
Phase icon
Phase
-1
Status icon
Status
Recruiting Now
Medical Condition icon
Medical Condition
Medical Research

How is Plaque Psoriasis treated?

Medical Condition icon
Medical Condition
A short sentence to introduce what to expect in the about condition section
Learn more
Study icon
The Study
A short sentence to introduce what to expect in the about condition section
Learn more
Clinical Trials icon
About Clinical Trials
A short sentence to introduce what to expect in the about condition section
Learn more

Your Journey

01
Receiving the medication
You would receive etanercept (Enbrel) twice a week for 12 weeks and then once a week for 12 weeks. Etanercept, as well as study related medical care, is provided at no cost.
02
Visiting the study site
Study participation involves approximately 8 visits to your local study center over 6 to 7 months.
03
Follow-up
There would also be a follow-up telephone call 30days after completing the study. No visits are required after participation is complete.

Call 1800-9860-568 now to find out if you are eligible.